Pherecydes Pharma is a biotechnology company developing phage therapies for fighting bacterial infections that is headquartered in Romainville, France and was founded in 2006 by Jerome Gabard and Manuel Gea.
On December 1, 2014 Pherecydes Pharma completed their series A funding round with €1.9 million in funding from Auriga Partners.
On January 16, 2018 Pherecydes Pharma completed their series A funding round with €8.7 million in funding from Go Capital (lead investor), Omnes Capital, FaDiese, Auriga Partners, and ACE Management.
Biotech raises funds to help produce phage therapies for bacterial infections
Dawson SewellWriting about startups.
Katrina-Kay PettittData Duchess @ Golden
Elena RubanFreelancer now. Graduated from Financial University
Meredith HanelMedical Genetics PhD, following life science applications that improve the health of humans and our planet.
Erin Scherfnerloading information...
Lax MariappanTechnopreneur, Open source enthusiast, author, speaker. Co-founder of Eternus Global. Crafting applications for the medical industry.
Neelam JhaveriTechno Geek + Gamer + Fashionista + Sense of Humor = It's ME
Henry OgollaPassionate about reading and writing.
Jessica KarpinskiI'm a knowledge seeker with a thirst to understand how the world is connected.
Vlad BotushninuI am a beginner programmer, I study IT sphere and cryptocurrencies